Evidence map›Paper›PMID 39045401›Full record

ArticleRSC advances2024

Phytofabricated ZnO-NPs mediated by

Oktavina Kartika Putri, Lina Oktavia Rahayu, Yuly Kusumawati, Arif Fadlan, Riki Subagyo, Mardi Santoso

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oktavina Kartika PutriDepartment of Chemistry, Institut Teknologi Sepuluh Nopember Surabaya 60111 Indonesia y_kusumawati@chem.its.ac.id.ORCID https://orcid.org/0000-0001-6599-0648
Lina Oktavia RahayuDepartment of Pharmacy, Politeknik Kesehatan Putra Indonesia Malang Malang 65122 Indonesia.
Yuly KusumawatiDepartment of Chemistry, Institut Teknologi Sepuluh Nopember Surabaya 60111 Indonesia y_kusumawati@chem.its.ac.id.ORCID https://orcid.org/0000-0002-2079-3584
Arif FadlanDepartment of Chemistry, Institut Teknologi Sepuluh Nopember Surabaya 60111 Indonesia y_kusumawati@chem.its.ac.id.ORCID https://orcid.org/0000-0002-6138-4015
Riki SubagyoDepartment of Chemistry, Institut Teknologi Sepuluh Nopember Surabaya 60111 Indonesia y_kusumawati@chem.its.ac.id.ORCID https://orcid.org/0000-0002-7622-9114
Mardi SantosoDepartment of Chemistry, Institut Teknologi Sepuluh Nopember Surabaya 60111 Indonesia y_kusumawati@chem.its.ac.id.ORCID https://orcid.org/0000-0003-0636-8386

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc oxide nanoparticles (ZnO-NPs) have provided promising potential in the biomedical field, including the ability to overcome various health problems. Diosgenin is used to treat multiple health disorders but has very low solubility in water. Using ZnO-NPs as a diosgenin delivery vehicle was expected to increase the solubility of diosgenin, which would affect its bioavailability. This study demonstrates phytofabrication and characterization of ZnO-NPs, loading of diosgenin onto the ZnO-NPs, characterization of the product (ZnO-NPs/diosgenin), and evaluations of diosgenin release. Phytofabrication of the ZnO-NPs was carried out with zinc precursors and

Identifiers

PMID39045401
PMCPMC11263970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.